CA2125483A1 - Cetylpyridinium chloride and domiphen bromide in organic solvent - Google Patents
Cetylpyridinium chloride and domiphen bromide in organic solventInfo
- Publication number
- CA2125483A1 CA2125483A1 CA002125483A CA2125483A CA2125483A1 CA 2125483 A1 CA2125483 A1 CA 2125483A1 CA 002125483 A CA002125483 A CA 002125483A CA 2125483 A CA2125483 A CA 2125483A CA 2125483 A1 CA2125483 A1 CA 2125483A1
- Authority
- CA
- Canada
- Prior art keywords
- microcapsules
- breath
- microcapsule
- salts
- gelatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Abstract
The present invention relates to oral compositions in the form of microcapsules which reduce oral bacteria and provide long lasting breath protection.
Description
CETYLPYRIDINIUM CHI,ORIDE AND DOMIPHEN
BROMIDE IN ORGANIC SOLVENT
TECHNICAl FIEID
The present invention relates to ora1 compositions in the form of microcapsules which reduce oral bacteria and provide long lasting breath protection.
BACKG~OUND ~F THE INYE~TIO~
The use of breath control composit~ons such as breath mints, mouthwashes, chew~ng gums, etc. is widespread in most of the developed countries of the world. Another ~orm which has been used are mlcrocapsules containing a flavorant or other breath protection ag0nt. These execut10ns ha~e acceptance du~ not only to their usefu~ness away from a plac~ to expectorate mouthwashes but alss due to the fact that they can be sw~llowed when the user does not need any more of the actives or doesn't want the microcapsule in the mouth any longer.
Although microcapsules have been used, there are problems associated with incorporating certain breath protection agents/
antimicrobials into the core. Oftentimes the wali of the micro-capsule may develop imperfections and cause lass of the contents prematurely. Additionally, the actiYes may not be easily solubilized in the materials ~sually present in the core.
The prior art discloses a ;variety of means for providing breath protection and reducing oral bacteria. Included among such means are sprays disclosed in U.S. 3~431.208. March 4. 1969 to Bailev. Particles containing an adhesive member are disclosed in U.S. 3.911.099. October 7. 1975 to Pen Fonev et al. Another farm is a mouthwash concentrate in a unit dosage cup as disclosed in V.S. 4~312.889. Ja~nuarv 26. 1982 to Melsheimer. All of these references are incorporated herein by reference.
The present inventors have found that by incorporating the breath control/antimicrobial actives into the core of the micro-capsule along with organic diluents, problems associated with other microcapsule executions`can be avoided.
~T~TU~E ~IEE~
W 0 93/11754 2 1 2 S 4 ~ 3 2 PCT/US92/ 10500 It is therefore an object of the present invention to provide improved microcapsules~
It is another object of the present invention to provide microcapsules which provide improved breath control and reduce oral bacteria.
It is still another object of the present invention to provide improved methods of providing breath control and reducing oral bacteria.
These and other objects will become more apparent from the detailed description wh;ch follows.
All percentages and ratios used here;n are by weight unless otherwise specified. Add1tional1y, all measurements aré made at 25-C unless otherwise specified, SUMMARY Of THE INVENTION
The present invention in ane of its aspects relates to microcapsules which contain breath control actives/antimicrobials in the core of the microcapsule along with an organic d;luent.
DETAILED DESCRIPTION OE THE INVENJION
The essential as well as optional çomponents of the capsules of the present invention are described in the following para-graphs.
Ca~sule Shell Material:
The shell material of the microcapsules of the present invention can be any materials which are suitable for ingestiffh as well as retention in the oral cavity. Materials which are suit-able include gelatin, polyvinyl alcohols, waxes, gums and sugar candy type materials used in cough drops and mints, for example.
The shell material is used to form any of a wide variety of shapes such as spheres, oblong shapes, disks, puffed squares and cylinders. The shell thickness is preferably ;n the range of about 30um to about 2mm, preferably from ~bout 70um to about llOum. If the microcapsules are spherical, the particle diameter is generally in the range of from about 2mm to about 9mm, preferably from about 3mm to about 7mm.
.
-2125~83 WO 93/11754 P~/US92/10500 Breath Control Aqents/Antimicrobials Present in the Core:
The breath control agents used in the cores of the micro-capsules include quaternary ammonium salts such as pyridiniu~
salts (e.g., cetyl pyridinium ch1Oride), domiphen bromide, other cationic materials such as chlorhexidine salts, zinc salts and copper salts. Other organic agents such as triclosan and other noncationic water insoluble agents are a1so useful herein. Such materials are disc1Osed in U.S. Patent 5,043,154, August 27, 1991, incorporated by reference herein.
These breath control/antimicrobial agents are used in an amount of from about 0.001% to about 2%, preferably from about 0.005/O to about 1% of the total core contents.
Diluents for Use in Microca~sule Core:
The solubilizing agent for the breath control/antimicrobial agents used in the cores of the present microcapsules can be any of a number of materials. Preferred are ails such as corn, olive, rapeseed, sesame, peanut or sunflower. Other preferred materials are triglycerides such as Captex 300. These are used in an amount of from about 20% to about 8~h, preferably from about 65% to about 70% of the total capsu1e weight.
Additional Aaents Suitable for U~e in the Core of Ca~sule:
The core of the microcapsules of this invention may contain any number of addittonal materials to provide additional efficacy and/or sensory perceptions. Such agents may include flavo~ing agents such as thymol, eucalyptol, menthol, methyl salicylate or witch hazel. These agents are used in an amount of from about .1%
to about 25%, preferably from about 10% to about 15% of the total capsule weight.
In additi~on, a variety of sweetening agents such as sugars, corn syrups, saccharin or aspartame may also be included in the core! These~agents are used in an amount of from about .1% to about 5%, preferably from about .35% to about .5% of the total capsule weight.
Method of Manufacture:
The capsules of the present invention can be made using a variety of techniques. One method is described after the following examples.
W 0 93/11754 2 1 2 S 4 ~ 3 -4- PCT/USg2/~0500 Industrial APP1 icabilitv:
The capsules of the present invention are used by placing the capsules into the mouth and retaining them therein f~r a period sufficient to provide the desired effect.
The following examples further describe and demonstrate preferred embodiments within the scope of the present invention.
The examples are given solely for the purposes of illustration and are not to be construed as illustrative of limitations of this invention. Many variations thereof are possible without departing from the invention's spirit and scope.
The fo110wing compositions/capsules are representative of the present invention.
ComPonent ,Weiqht %
~5 Gelatin 12.578 12.328 12.578 17.578 Sorbitol Solution 2.046 2.05 2.046 2.046 (70/, Aqueous) Saccharin ~ ~ 0.372 0.500 0.372 0.450 FD&C Blue #1 0.002 0.002 0.002 FD&C Yellow #5 0.002 - 0.002 0.004 Captex 3001 72.i4Q 70.00 71.925 66.142 Flavor 12.750 15.00 12.75 13.500 Cetyl Pyridinium 0.100 - - - S
Chloride ; ~
Domiphen Bromide ~ O.OIC - - -; Chlorhexidine ; - 0.12 - -ZnC12 ~ 0.025 Sodium Lauryl ~Sulfate - - 0.300 Tricl osan - - - 0.28 1) Captex 300'is~a triglyce'ride supplied by Capitol City Product, Columbus, Ohio.
` The above~compositions~are prepared by mixing the components ` of the core in one cont~ainer and the components of the shell in another container. The shell materials are heated to provide a :
fluid medium. The ~`core ~and shell materials are then pumped :
.
:::
W O 93/1175q 212 5 4 X ~ 5 PCT/US92/10500 .
separately to a two-fluid nozzle submerged in an organic carrier medium. The capsules formed are allowed to cool and stiffen.
They are then denatured and separated for further handling.
In the above compositions any of a wide variety of other shell materials, breath control agents, sweeteners as well as other companents may be used in place of or in combination with the components listed above, WHA~I ~ I~L~IM~4.
10 ' lS
, :
: 25 "
: ~
~ 35 ~ :~
"; :: ` : :
, ,
BROMIDE IN ORGANIC SOLVENT
TECHNICAl FIEID
The present invention relates to ora1 compositions in the form of microcapsules which reduce oral bacteria and provide long lasting breath protection.
BACKG~OUND ~F THE INYE~TIO~
The use of breath control composit~ons such as breath mints, mouthwashes, chew~ng gums, etc. is widespread in most of the developed countries of the world. Another ~orm which has been used are mlcrocapsules containing a flavorant or other breath protection ag0nt. These execut10ns ha~e acceptance du~ not only to their usefu~ness away from a plac~ to expectorate mouthwashes but alss due to the fact that they can be sw~llowed when the user does not need any more of the actives or doesn't want the microcapsule in the mouth any longer.
Although microcapsules have been used, there are problems associated with incorporating certain breath protection agents/
antimicrobials into the core. Oftentimes the wali of the micro-capsule may develop imperfections and cause lass of the contents prematurely. Additionally, the actiYes may not be easily solubilized in the materials ~sually present in the core.
The prior art discloses a ;variety of means for providing breath protection and reducing oral bacteria. Included among such means are sprays disclosed in U.S. 3~431.208. March 4. 1969 to Bailev. Particles containing an adhesive member are disclosed in U.S. 3.911.099. October 7. 1975 to Pen Fonev et al. Another farm is a mouthwash concentrate in a unit dosage cup as disclosed in V.S. 4~312.889. Ja~nuarv 26. 1982 to Melsheimer. All of these references are incorporated herein by reference.
The present inventors have found that by incorporating the breath control/antimicrobial actives into the core of the micro-capsule along with organic diluents, problems associated with other microcapsule executions`can be avoided.
~T~TU~E ~IEE~
W 0 93/11754 2 1 2 S 4 ~ 3 2 PCT/US92/ 10500 It is therefore an object of the present invention to provide improved microcapsules~
It is another object of the present invention to provide microcapsules which provide improved breath control and reduce oral bacteria.
It is still another object of the present invention to provide improved methods of providing breath control and reducing oral bacteria.
These and other objects will become more apparent from the detailed description wh;ch follows.
All percentages and ratios used here;n are by weight unless otherwise specified. Add1tional1y, all measurements aré made at 25-C unless otherwise specified, SUMMARY Of THE INVENTION
The present invention in ane of its aspects relates to microcapsules which contain breath control actives/antimicrobials in the core of the microcapsule along with an organic d;luent.
DETAILED DESCRIPTION OE THE INVENJION
The essential as well as optional çomponents of the capsules of the present invention are described in the following para-graphs.
Ca~sule Shell Material:
The shell material of the microcapsules of the present invention can be any materials which are suitable for ingestiffh as well as retention in the oral cavity. Materials which are suit-able include gelatin, polyvinyl alcohols, waxes, gums and sugar candy type materials used in cough drops and mints, for example.
The shell material is used to form any of a wide variety of shapes such as spheres, oblong shapes, disks, puffed squares and cylinders. The shell thickness is preferably ;n the range of about 30um to about 2mm, preferably from ~bout 70um to about llOum. If the microcapsules are spherical, the particle diameter is generally in the range of from about 2mm to about 9mm, preferably from about 3mm to about 7mm.
.
-2125~83 WO 93/11754 P~/US92/10500 Breath Control Aqents/Antimicrobials Present in the Core:
The breath control agents used in the cores of the micro-capsules include quaternary ammonium salts such as pyridiniu~
salts (e.g., cetyl pyridinium ch1Oride), domiphen bromide, other cationic materials such as chlorhexidine salts, zinc salts and copper salts. Other organic agents such as triclosan and other noncationic water insoluble agents are a1so useful herein. Such materials are disc1Osed in U.S. Patent 5,043,154, August 27, 1991, incorporated by reference herein.
These breath control/antimicrobial agents are used in an amount of from about 0.001% to about 2%, preferably from about 0.005/O to about 1% of the total core contents.
Diluents for Use in Microca~sule Core:
The solubilizing agent for the breath control/antimicrobial agents used in the cores of the present microcapsules can be any of a number of materials. Preferred are ails such as corn, olive, rapeseed, sesame, peanut or sunflower. Other preferred materials are triglycerides such as Captex 300. These are used in an amount of from about 20% to about 8~h, preferably from about 65% to about 70% of the total capsu1e weight.
Additional Aaents Suitable for U~e in the Core of Ca~sule:
The core of the microcapsules of this invention may contain any number of addittonal materials to provide additional efficacy and/or sensory perceptions. Such agents may include flavo~ing agents such as thymol, eucalyptol, menthol, methyl salicylate or witch hazel. These agents are used in an amount of from about .1%
to about 25%, preferably from about 10% to about 15% of the total capsule weight.
In additi~on, a variety of sweetening agents such as sugars, corn syrups, saccharin or aspartame may also be included in the core! These~agents are used in an amount of from about .1% to about 5%, preferably from about .35% to about .5% of the total capsule weight.
Method of Manufacture:
The capsules of the present invention can be made using a variety of techniques. One method is described after the following examples.
W 0 93/11754 2 1 2 S 4 ~ 3 -4- PCT/USg2/~0500 Industrial APP1 icabilitv:
The capsules of the present invention are used by placing the capsules into the mouth and retaining them therein f~r a period sufficient to provide the desired effect.
The following examples further describe and demonstrate preferred embodiments within the scope of the present invention.
The examples are given solely for the purposes of illustration and are not to be construed as illustrative of limitations of this invention. Many variations thereof are possible without departing from the invention's spirit and scope.
The fo110wing compositions/capsules are representative of the present invention.
ComPonent ,Weiqht %
~5 Gelatin 12.578 12.328 12.578 17.578 Sorbitol Solution 2.046 2.05 2.046 2.046 (70/, Aqueous) Saccharin ~ ~ 0.372 0.500 0.372 0.450 FD&C Blue #1 0.002 0.002 0.002 FD&C Yellow #5 0.002 - 0.002 0.004 Captex 3001 72.i4Q 70.00 71.925 66.142 Flavor 12.750 15.00 12.75 13.500 Cetyl Pyridinium 0.100 - - - S
Chloride ; ~
Domiphen Bromide ~ O.OIC - - -; Chlorhexidine ; - 0.12 - -ZnC12 ~ 0.025 Sodium Lauryl ~Sulfate - - 0.300 Tricl osan - - - 0.28 1) Captex 300'is~a triglyce'ride supplied by Capitol City Product, Columbus, Ohio.
` The above~compositions~are prepared by mixing the components ` of the core in one cont~ainer and the components of the shell in another container. The shell materials are heated to provide a :
fluid medium. The ~`core ~and shell materials are then pumped :
.
:::
W O 93/1175q 212 5 4 X ~ 5 PCT/US92/10500 .
separately to a two-fluid nozzle submerged in an organic carrier medium. The capsules formed are allowed to cool and stiffen.
They are then denatured and separated for further handling.
In the above compositions any of a wide variety of other shell materials, breath control agents, sweeteners as well as other companents may be used in place of or in combination with the components listed above, WHA~I ~ I~L~IM~4.
10 ' lS
, :
: 25 "
: ~
~ 35 ~ :~
"; :: ` : :
, ,
Claims (10)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. Microcapsules suitable for reducing oral bacteria and providing breath protection comprising a shell material suitable for use in the mouth and ingesting and a core composition comprising a breath protection agent/anti-microbial selected from the group consisting of quaternary ammonium salts, other cationic salts, copper salts, zinc salts, triclosan and mixtures thereof and an organic diluent.
2. Microcapsules according to Claim 1 wherein the shell material is selected from the group consisting of polyvinyl alcohol, gelatin, waxes, gums and sugar candies.
3. Microcapsules according to Claim 2 wherein the microcapsule is in the form of a sphere, oblong, disk, a puffed square, or a cylinder and the breath control agent is a quaternary ammonium salt.
4. Microcapsules according to Claim 3 wherein the microcapsules are in the form of spheres.
5. Microcapsules according to Claim 4 wherein the microcapsules are from about 2mm to about 9mm in diameter and the shell wall thickness is from about 30µm to about 2mm.
6. Microcapsules according to Claim 5 wherein the shell material is gelatin.
7. A method of reducing oral bacteria and breath odor in the mouth wherein capsules according to Claim 1 are placed in the mouth and left therein for a time sufficient to provide a benefit.
8. A method according to Claim 7 wherein the microcapsule shell is made of gelatin.
9. A method according to Claim 8 wherein the breath control/
antimicrobial active is selected from the group consisting of cetyl pyridinium chloride, domiphen bromide and mixtures thereof,
antimicrobial active is selected from the group consisting of cetyl pyridinium chloride, domiphen bromide and mixtures thereof,
10. A method according to Claim 9 wherein the microcapsule is in the form of a sphere.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80543291A | 1991-12-11 | 1991-12-11 | |
US07/805,432 | 1991-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2125483A1 true CA2125483A1 (en) | 1993-06-24 |
Family
ID=25191562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002125483A Abandoned CA2125483A1 (en) | 1991-12-11 | 1992-12-07 | Cetylpyridinium chloride and domiphen bromide in organic solvent |
Country Status (7)
Country | Link |
---|---|
US (2) | US5286496A (en) |
EP (1) | EP0616526A1 (en) |
CA (1) | CA2125483A1 (en) |
FI (1) | FI942765A (en) |
NO (1) | NO942170D0 (en) |
TR (1) | TR27527A (en) |
WO (1) | WO1993011754A1 (en) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620707A (en) * | 1993-06-29 | 1997-04-15 | The Procter & Gamble Company | Beadlets for customization of flavor and sweetener in a beverage |
US5370864A (en) * | 1993-06-29 | 1994-12-06 | The Procter & Gamble Company | Breath protection microcapsules |
SI0767654T1 (en) * | 1994-07-25 | 2003-04-30 | Warner-Lambert Company | Antiseptic dentifrice |
US5616315A (en) * | 1994-10-13 | 1997-04-01 | Gillette Canada Inc. | Particles including degradable material and anti-microbial agent |
AU4988696A (en) * | 1995-03-29 | 1996-10-16 | Procter & Gamble Company, The | Antitussive microcapsules |
US5631024A (en) * | 1995-05-22 | 1997-05-20 | Enviroquest, Ltd. | Medicaments for beneficial insects and method |
JP4330175B2 (en) * | 1995-06-07 | 2009-09-16 | デュレクト コーポレイション | Controlled delivery system with high viscosity liquid |
US7833543B2 (en) * | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
CN1044668C (en) * | 1996-07-10 | 1999-08-18 | 高谦 | Vegetable oil composition |
DE19652257A1 (en) * | 1996-12-16 | 1998-06-18 | Lohmann Therapie Syst Lts | Individually dosed, film-like dosage form that quickly disintegrates on contact with liquid and contains active ingredients and especially flavorings |
US6592912B1 (en) | 1997-12-30 | 2003-07-15 | Wm. Wrigley Jr. Company | Method of controlling release of antimicrobial agents from chewing gum and gum produced thereby |
CA2315726C (en) * | 1997-12-30 | 2004-09-07 | Wm. Wrigley Jr. Company | Method of controlling release of antimicrobial agents in chewing gum and gum produced thereby |
US6174514B1 (en) * | 1999-04-12 | 2001-01-16 | Fuisz Technologies Ltd. | Breath Freshening chewing gum with encapsulations |
US6436369B2 (en) * | 1998-12-17 | 2002-08-20 | Wm. Wrigley Jr. Company | Anti-plaque emulsions and products containing same |
DE19905585A1 (en) * | 1999-02-11 | 2000-08-17 | Beiersdorf Ag | Use of quaternary ammonium compounds as antiperspirants |
GB9917547D0 (en) * | 1999-07-26 | 1999-09-29 | Orafresh Limited | Dentifrice compositions |
US20010043941A1 (en) * | 2000-03-23 | 2001-11-22 | Hiep Huatan | Oral formulations of medicaments |
WO2002002745A2 (en) * | 2000-07-05 | 2002-01-10 | Islet Technology, Inc. | Method and system for consistent and effective encapsulation of biological material |
US6589562B1 (en) * | 2000-10-25 | 2003-07-08 | Salvona L.L.C. | Multicomponent biodegradable bioadhesive controlled release system for oral care products |
US6887493B2 (en) * | 2000-10-25 | 2005-05-03 | Adi Shefer | Multi component controlled release system for oral care, food products, nutraceutical, and beverages |
US6565873B1 (en) * | 2000-10-25 | 2003-05-20 | Salvona Llc | Biodegradable bioadhesive controlled release system of nano-particles for oral care products |
JP2002277816A (en) * | 2001-03-21 | 2002-09-25 | Minolta Co Ltd | Image display device |
AP2003002930A0 (en) * | 2001-06-11 | 2003-12-31 | Warner Lambert Co | Breath protection microcapsules |
US20030228368A1 (en) * | 2001-09-28 | 2003-12-11 | David Wynn | Edible solid composition and dosage form |
FR2832632B1 (en) | 2001-11-26 | 2004-04-23 | Mane Fils V | QUICK SOLUBILIZATION AND RELEASE CAPSULE |
US7357949B2 (en) * | 2001-12-21 | 2008-04-15 | Agion Technologies Inc. | Encapsulated inorganic antimicrobial additive for controlled release |
US20030118658A1 (en) * | 2001-12-21 | 2003-06-26 | Trogolo Jeffrey A. | High aspect ratio encapsulated inorganic antimicrobial additive for controlled release |
US6579513B1 (en) | 2002-01-03 | 2003-06-17 | Playtex Products, Inc. | Hygiene mouthspray composition |
US20030228336A1 (en) * | 2002-06-07 | 2003-12-11 | Carla Gervasio | Cosmetic compositions and container therefor |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
ES2553136T3 (en) | 2002-12-13 | 2015-12-04 | Durect Corporation | Oral drug delivery system comprising high viscosity liquid vehicle materials |
CA2557113A1 (en) * | 2004-02-17 | 2005-08-25 | Symrise Gmbh & Co. Kg | Coated spherical seamless filled capsules |
US8753665B2 (en) | 2004-09-17 | 2014-06-17 | Durect Corporation | Controlled delivery system |
WO2006096412A1 (en) * | 2005-03-04 | 2006-09-14 | Wm. Wrigley Jr. Company | Center-filled jelly confections |
US20090191510A1 (en) * | 2005-06-22 | 2009-07-30 | Cao Group, Inc. | Periodontal treatment employing applied ultrasonic energy |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
EP1917003A1 (en) * | 2005-08-16 | 2008-05-07 | Symrise GmbH & Co. KG | Seamless coated spherical filled capsules |
US20070053972A1 (en) * | 2005-09-08 | 2007-03-08 | Cadbury Adams Usa Llc. | Gelatin capsules containing actives |
ITMI20052342A1 (en) * | 2005-12-06 | 2007-06-07 | Perfetti Van Melle Spa | FORMULATIONS FOR ORAL HYGIENE IN THE FORM OF CAPSULES |
MX2008011072A (en) * | 2006-02-28 | 2008-09-05 | Procter & Gamble | Benefit agent containing delivery particle. |
US20080031961A1 (en) * | 2006-08-01 | 2008-02-07 | Philip Andrew Cunningham | Benefit agent containing delivery particle |
PL2117521T3 (en) | 2006-11-03 | 2012-11-30 | Durect Corp | Transdermal delivery systems comprising bupivacaine |
JP2010509447A (en) * | 2006-11-22 | 2010-03-25 | ザ プロクター アンド ギャンブル カンパニー | Beneficial agent-containing delivery particles |
US20080152677A1 (en) * | 2006-12-20 | 2008-06-26 | Roberto Colle | Oral hygiene formulations in the form of capsules |
CN101611129B (en) * | 2007-02-15 | 2014-06-18 | 宝洁公司 | Benefit agent delivery compositions |
MX2009013494A (en) | 2007-06-11 | 2010-01-18 | Procter & Gamble | Benefit agent containing delivery particle. |
AU2008335809A1 (en) | 2007-12-06 | 2009-06-18 | Durect Corporation | Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
WO2011075556A1 (en) * | 2009-12-18 | 2011-06-23 | The Procter & Gamble Company | Composition comprising encapsulates, and process for making them |
US20110271968A1 (en) * | 2010-05-07 | 2011-11-10 | Carolyn Rierson Carpenter | Filtered Cigarette With Modifiable Sensory Characteristics |
CN105120659A (en) | 2013-03-15 | 2015-12-02 | 度瑞公司 | Compositions with a rheological modifier to reduce dissolution variability |
KR20220140711A (en) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | Reduced Impurity Sustained Release Drug Delivery Systems and Related Methods |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2311923A (en) * | 1939-06-08 | 1943-02-23 | Iodent Chemical Company | Cough drop |
US2446792A (en) * | 1943-08-28 | 1948-08-10 | Wm S Merrell Co | Substituted pyridinium and piperidinium compounds |
GB1060258A (en) * | 1964-12-05 | 1967-03-01 | Sandoz Products Ltd | Improvements in or relating to pharmaceutical pastilles |
US3431208A (en) * | 1965-11-17 | 1969-03-04 | Schering Corp | Denture spray |
FR2051483A1 (en) * | 1969-05-19 | 1971-04-09 | Midy Centre Rech M | Proteolytic enzymes for treating throat - infections |
US3959457A (en) * | 1970-06-05 | 1976-05-25 | Temple University | Microparticulate material and method of making such material |
US3832460A (en) * | 1971-03-19 | 1974-08-27 | C Kosti | Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue |
JPS518876B2 (en) * | 1972-10-03 | 1976-03-22 | ||
US4039653A (en) * | 1974-01-23 | 1977-08-02 | Defoney, Brenman, Mayes & Baron | Long-acting articles for oral delivery and process |
US3911099A (en) * | 1974-01-23 | 1975-10-07 | Defoney Brenman Mayes & Baron | Long-acting articles for oral delivery and process |
US3957964A (en) * | 1974-01-30 | 1976-05-18 | Colgate-Palmolive Company | Dentifrice containing encapsulated flavoring |
US4071614A (en) * | 1975-06-03 | 1978-01-31 | Colgate Palmolive Company | Dentifrice containing encapsulated flavoring |
NL180807C (en) * | 1975-12-26 | 1987-05-04 | Morishita Jintan Co | DEVICE FOR MANUFACTURING SEAMLESS MATERIAL FILLED CAPSULES. |
DE2712161C2 (en) * | 1977-03-19 | 1983-01-05 | Blendax-Werke R. Schneider Gmbh & Co, 6500 Mainz | Dental and oral care products |
US4196189A (en) * | 1977-03-19 | 1980-04-01 | Blendax-Werke R. Schneider | Dental and oral hygiene preparations |
US4292028A (en) * | 1979-07-13 | 1981-09-29 | Arthur Barr | Cosmetic breath freshener and palate coolant composition and method of use |
US4260596A (en) * | 1979-08-13 | 1981-04-07 | Bristol-Myers Company | Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same |
US4409202A (en) * | 1980-04-07 | 1983-10-11 | Nabisco Brands, Inc. | Breath freshener composition and method |
US4312889A (en) * | 1980-04-30 | 1982-01-26 | Design & Funding, Inc. | Liquid carrier concentrate for pre-loaded cup |
US4329333A (en) * | 1980-11-24 | 1982-05-11 | Arthur Barr | Method for the oral treatment of dogs and other animals |
US4481157A (en) * | 1982-04-27 | 1984-11-06 | Morishita Jintan Co., Ltd. | Method and apparatus for production of microcapsules |
US4597959A (en) * | 1982-04-30 | 1986-07-01 | Arthur Barr | Sustained release breath freshener, mouth and palate coolant wafer composition and method of use |
JPS5953410A (en) * | 1982-09-20 | 1984-03-28 | Fujisawa Pharmaceut Co Ltd | Novel soft capsule agent |
US4422985A (en) * | 1982-09-24 | 1983-12-27 | Morishita Jintan Co., Ltd. | Method and apparatus for encapsulation of a liquid or meltable solid material |
JPS59131355A (en) * | 1983-01-17 | 1984-07-28 | 森下仁丹株式会社 | Multiple soft capsule |
US4749575A (en) * | 1983-10-03 | 1988-06-07 | Bio-Dar Ltd. | Microencapsulated medicament in sweet matrix |
FR2570604B1 (en) * | 1984-09-25 | 1988-12-30 | Pharmedis Sa | NEW PROCESS FOR THE ENCAPSULATION OF VOLATILE SUBSTANCES AND THE PHYTO-AROMATIC COMPOSITIONS THUS OBTAINED |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4765984A (en) * | 1986-01-22 | 1988-08-23 | Colgate-Palmolive Company | Stable single unit dose oral product |
US4710384A (en) * | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
US4762719A (en) * | 1986-08-07 | 1988-08-09 | Mark Forester | Powder filled cough product |
US4847090A (en) * | 1986-11-07 | 1989-07-11 | Warner-Lambert Company | Confection product and method for making same |
US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
FR2608456B1 (en) * | 1986-12-18 | 1993-06-18 | Mero Rousselot Satia | MICROCAPSULES BASED ON GELATIN AND POLYSACCHARIDES AND PROCESS FOR OBTAINING THEM |
US5004595A (en) * | 1986-12-23 | 1991-04-02 | Warner-Lambert Company | Multiple encapsulated flavor delivery system and method of preparation |
US5043154A (en) * | 1987-01-30 | 1991-08-27 | Colgate-Palmolive Co. | Antibacterial, antiplaque, anticalculus oral composition |
US4857335A (en) * | 1987-03-27 | 1989-08-15 | Lim Technology Laboratories, Inc. | Liquid controlled release formulations and method of producing same via multiple emulsion process |
US4906488A (en) * | 1987-05-01 | 1990-03-06 | Arcade, Inc. | Modification of permeant |
US4797234A (en) * | 1987-06-19 | 1989-01-10 | Temple University | Production of sustained release composition from salt-form reactants |
JPH0725649B2 (en) * | 1987-10-12 | 1995-03-22 | 而至歯科工業株式会社 | Disinfectant-containing alginate impression material |
JP2540892B2 (en) * | 1987-12-11 | 1996-10-09 | ライオン株式会社 | Oral composition |
US5061106A (en) * | 1988-03-08 | 1991-10-29 | Colgate-Palmolive Company | Toothbrush with slow release of disinfectant and antibacterial agents and method of manufacturing the same |
JPH01231934A (en) * | 1988-03-10 | 1989-09-18 | Lion Corp | Production of microcapsule |
US5064650A (en) * | 1988-04-19 | 1991-11-12 | Southwest Research Institute | Controlled-release salt sensitive capsule for oral use and adhesive system |
WO1989010117A1 (en) * | 1988-04-19 | 1989-11-02 | Southwest Research Institute | Controlled release of active ingredients from capsules having a salt sensitive shell material |
US5164195A (en) * | 1988-04-19 | 1992-11-17 | Southwest Research Institute | Method of oral delivery with an adherent controlled-release salt sensitive capsule |
US4861268A (en) * | 1988-06-13 | 1989-08-29 | Transpharm Group | Tooth-anchored beneficial agent delivery device |
US4917892A (en) * | 1988-06-28 | 1990-04-17 | Temple University | Encapsulated topical delivery system |
WO1990002655A1 (en) * | 1988-09-06 | 1990-03-22 | Encapsulation Systems, Inc. | Realease assist microcapsules |
FR2643261A1 (en) * | 1989-02-22 | 1990-08-24 | Tonelli Jean Charles | Improvement to dentifrices |
US5084278A (en) * | 1989-06-02 | 1992-01-28 | Nortec Development Associates, Inc. | Taste-masked pharmaceutical compositions |
WO1990015592A1 (en) * | 1989-06-12 | 1990-12-27 | Patrick John Shanahan | Anti-plaque dentifrice |
US5098725A (en) * | 1989-06-30 | 1992-03-24 | Bio-Dar, Ltd. | Heat stabilized flavoring agents coated with hydrogenated castor oil |
US5013557A (en) * | 1989-10-03 | 1991-05-07 | Warner-Lambert Company | Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same |
FR2652741B1 (en) * | 1989-10-10 | 1994-03-04 | Laboratoires Care System | ANTIMICROBIAL COMPOSITION FOR APPLICATION TO THE SKIN, APPLICATIONS AS A BODY DEODORANT AND CUTANEOUS BACTERICIDE. |
DK546289D0 (en) * | 1989-11-02 | 1989-11-02 | Danochemo As | carotenoid |
US5008106A (en) * | 1989-12-14 | 1991-04-16 | Gaf Chemicals Corporation | Method for reducing the microbial content of surfaces with a microbiocidal, anhydrous complex of PVP-H2 O2 |
US5132117A (en) * | 1990-01-11 | 1992-07-21 | Temple University | Aqueous core microcapsules and method for their preparation |
JPH0684294B2 (en) * | 1990-05-29 | 1994-10-26 | サンスター株式会社 | Oral composition |
US5135747A (en) * | 1991-05-17 | 1992-08-04 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Deodorant/antiperspirant products with fragrance and encapsulated odor counteractant |
-
1992
- 1992-12-07 WO PCT/US1992/010500 patent/WO1993011754A1/en not_active Application Discontinuation
- 1992-12-07 CA CA002125483A patent/CA2125483A1/en not_active Abandoned
- 1992-12-07 EP EP93900886A patent/EP0616526A1/en not_active Ceased
- 1992-12-09 TR TR01174/92A patent/TR27527A/en unknown
-
1993
- 1993-01-11 US US08/003,080 patent/US5286496A/en not_active Expired - Fee Related
- 1993-11-10 US US08/150,663 patent/US5382424A/en not_active Expired - Fee Related
-
1994
- 1994-06-10 NO NO942170A patent/NO942170D0/en unknown
- 1994-06-10 FI FI942765A patent/FI942765A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US5382424A (en) | 1995-01-17 |
US5286496A (en) | 1994-02-15 |
FI942765A0 (en) | 1994-06-10 |
FI942765A (en) | 1994-06-10 |
TR27527A (en) | 1995-06-07 |
WO1993011754A1 (en) | 1993-06-24 |
NO942170L (en) | 1994-06-10 |
EP0616526A1 (en) | 1994-09-28 |
NO942170D0 (en) | 1994-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2125483A1 (en) | Cetylpyridinium chloride and domiphen bromide in organic solvent | |
US5300305A (en) | Breath protection microcapsules | |
US5370864A (en) | Breath protection microcapsules | |
US4329333A (en) | Method for the oral treatment of dogs and other animals | |
AU682489B2 (en) | Reduced alcohol mouthwash antiseptic and antiseptic preparations | |
CA1149747A (en) | Toothpaste comprising a copper compound and a silica polishing agent useful for the prevention of the formation of dental plaque | |
DE69830542T2 (en) | Use of special polyamine polymers as antioxidants | |
EP1203575B1 (en) | Clear gel-type dentrifices | |
RU2481098C1 (en) | Oral care compositions increasing amount of soluble zinc | |
RU2697881C2 (en) | Stabilizing zinc oxide film in compositions for oral care | |
US6582682B2 (en) | Oral care compositions comprising stabilized chlorine dioxide | |
NL8700153A (en) | ORAL PRODUCT IN STABLE UNIT DOSE. | |
CA2452577A1 (en) | Soft capsules | |
RU2554807C2 (en) | Dissolvable films containing high concentrations of non-ionic surfactants such as polysorbates to enhance high solid loadings | |
US20080274148A1 (en) | Microcapsule Composition | |
EP1155683B1 (en) | Oral composition with an improved teeth whitening effect | |
US6506368B2 (en) | Process for producing blue microcapsules | |
EP2654671B1 (en) | Non-aqueous oral care composition containing dental occlusion actives | |
NZ240508A (en) | Oral compositions containing a 2- or 3-(8 to 16c alkyl)-4-hydroxyalkyl morpholine and a salt of a group 2 or transition metal | |
US6306372B1 (en) | Oral hygiene compositions which mask the burn sensation and the astringency of eucalyptol and zinc | |
NZ194341A (en) | Slow release breath freshener composition | |
WO1997016159A1 (en) | Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils | |
CA1257842A (en) | Antimicrobial lozenges | |
SK15362003A3 (en) | Breath protection microcapsules | |
CA1104939A (en) | Mellitic acids in antibacterial antiplaque compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |